Esophageal Squamous Cell Carcinoma
Showing 9976 - 10000 of >10,000
Advanced Gastrointestinal (GI) Malignancies, Hepatocellular Carcinoma, Gastric Cancer Trial in Worldwide (ADI-PEG 20 plus
Terminated
- Advanced Gastrointestinal (GI) Malignancies
- +3 more
- ADI-PEG 20 plus modified FOLFOX6
-
San Francisco, California
- +34 more
Apr 18, 2022
Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial in Houston (Larotrectinib Sulfate)
Recruiting
- Locally Advanced Malignant Solid Neoplasm
- Metastatic Malignant Solid Neoplasm
- Larotrectinib Sulfate
-
Houston, TexasM D Anderson Cancer Center
Apr 18, 2022
Biphasic Mesothelioma, Epithelioid Mesothelioma, Peritoneal Malignant Mesothelioma Trial in Chicago (Pembrolizumab, Laboratory
Active, not recruiting
- Biphasic Mesothelioma
- +9 more
- Pembrolizumab
- +2 more
-
Chicago, IllinoisUniversity of Chicago
Apr 18, 2022
Male Breast Carcinoma, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7 Trial in United States
Active, not recruiting
- Male Breast Carcinoma
- +4 more
- Bevacizumab
- +5 more
-
Jonesboro, Arkansas
- +452 more
Jan 13, 2023
Intraoperative Margin Assessment During Mohs Surgery
Withdrawn
- Squamous Cell Carcinoma (SCC)
- Basal Cell Carcinoma (BCC)
- Multimodal Spectroscopy (MMS)
- (no location specified)
Aug 17, 2018
MDS (MDS), Acute Myelogenous Leukemia (AML) Trial in United States (low dose 5'-azacitidine)
Active, not recruiting
- Myelodysplastic Syndromes (MDS)
- Acute Myelogenous Leukemia (AML)
- low dose 5'-azacitidine
-
Basking Ridge, New Jersey
- +6 more
Dec 1, 2022
Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia Trial in Tampa (drug, radiation, procedure)
Completed
- Non-Hodgkin's Lymphoma
- +7 more
- Fludarabine
- +7 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 14, 2021
Triple Negative Breast Cancer, Nonsmall Cell Lung Cancer Trial in Rocky Mount
Recruiting
- Triple Negative Breast Cancer
- Nonsmall Cell Lung Cancer
-
Rocky Mount, North CarolinaAccellacare of Rocky Mount -Dr. Bondy
May 26, 2023
Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)
Not yet recruiting
- Extensive-stage Small-cell Lung Cancer
- Trilaciclib
- +2 more
- (no location specified)
May 22, 2023
Recurrent Ovarian Cancer Trial in Chengdu (dendritic cell)
Not yet recruiting
- Recurrent Ovarian Cancer
- dendritic cell
-
Chengdu, Sichuan, Chinawest china second University, SICHUAN University, China
Feb 25, 2022
Mantle Cell Lymphoma Trial in Baltimore (Venetoclax Oral Tablet [Venclexta])
Recruiting
- Mantle Cell Lymphoma
- Venetoclax Oral Tablet [Venclexta]
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jun 29, 2022
Camrelizumab Combined With Apatinib and Hyperfractionated
Not yet recruiting
- Renal Cell Carcinoma
- camrelizumab+apatinib+hyperfractionated radiotherapy
- (no location specified)
Oct 26, 2020
Serum Basal Tryptase Levels in Healthy Children
Completed
- Basal Tryptasemia
- Tryptase dosage
-
Paris, FranceHôpital Necker-Enfants Malades
Dec 8, 2022
Selective PET Imaging of Astrocytes and Microglia in Alzheimer's
Recruiting
- Alzheimer Disease
- Healthy
- Positron Emission Tomography (PET) using two PET tracer under IND
-
Houston, TexasHouston Methodist Research Institute
Jan 20, 2023
Patients With Restenosis of Calcified Lesions
Recruiting
- Coronary Artery Calcification
- +3 more
- Coronary artery calcification lesions
-
Shenyang, Liaoning, ChinaShenyangNH
Jul 14, 2022
Abnormal Respiratory Cell Populations in Lung Cancer Screening
Not yet recruiting
- Lung Cancer
- (no location specified)
May 12, 2023
Non Small Cell Lung Cancer Metastatic, Advanced Melanoma Trial in Toronto, Montréal, Québec (FMT + ICI)
Recruiting
- Non Small Cell Lung Cancer Metastatic
- Advanced Melanoma
- FMT + ICI
-
Toronto, Ontario, Canada
- +3 more
Aug 19, 2022
Malignant Pleural Effusion Trial in Chandigarh (Doxycycline, Iodopovidine)
Active, not recruiting
- Malignant Pleural Effusion
- Doxycycline
- Iodopovidine
-
Chandigarh, IndiaBronchoscopy suite, PGIMER
Mar 20, 2021
Heart Failure Trial in Worldwide (Omecamtiv Mecarbil, Placebo, Standard of Care)
Completed
- Heart Failure
- Omecamtiv Mecarbil
- +2 more
-
Birmingham, Alabama
- +1033 more
Nov 2, 2021
B-cell Lymphoma Trial in Hangzhou (PD1 specific integrated anti-CD19 Chimeric Antigen Receptor T Cells)
Active, not recruiting
- B-cell Lymphoma
- PD1 specific integrated anti-CD19 Chimeric Antigen Receptor T Cells
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
Sep 28, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (IOV-2001, Low dose IL-2, High dose IL-2)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- IOV-2001
- +3 more
-
Tampa, Florida
- +5 more
Jan 31, 2022